KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Merck (MRK) over the last 15 years, with Q3 2025 value amounting to $7.7 billion.

  • Merck's Other Non-Current Liabilities rose 160.48% to $7.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 billion, marking a year-over-year increase of 160.48%. This contributed to the annual value of $6.5 billion for FY2024, which is 2646.72% down from last year.
  • Per Merck's latest filing, its Other Non-Current Liabilities stood at $7.7 billion for Q3 2025, which was up 160.48% from $7.0 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Other Non-Current Liabilities peaked at $12.2 billion during Q1 2021, and registered a low of $6.5 billion during Q4 2024.
  • In the last 5 years, Merck's Other Non-Current Liabilities had a median value of $8.3 billion in 2024 and averaged $8.4 billion.
  • As far as peak fluctuations go, Merck's Other Non-Current Liabilities soared by 598.27% in 2021, and later plummeted by 2646.72% in 2024.
  • Quarter analysis of 5 years shows Merck's Other Non-Current Liabilities stood at $9.4 billion in 2021, then decreased by 11.78% to $8.3 billion in 2022, then increased by 5.63% to $8.8 billion in 2023, then decreased by 26.47% to $6.5 billion in 2024, then rose by 18.5% to $7.7 billion in 2025.
  • Its last three reported values are $7.7 billion in Q3 2025, $7.0 billion for Q2 2025, and $6.7 billion during Q1 2025.